Literature DB >> 6895847

Activities of branched-chain 2-oxo acid dehydrogenase and its components in skin fibroblasts from normal and classical-maple-syrup-urine-disease subjects.

D T Chuang, W L Niu, R P Cox.   

Abstract

1. Comparisons of the activity and kinetics of the branched-chain 2-oxo acid dehydrogenase in cultured skin fibroblasts from normal and classical maple-syrup-urine-disease (MSUD) subjects provide a kinetic explanation for the enzyme defect. 2. In the intact cell assays, normal fibroblasts demonstrated hyperbolic kinetics with 3-methyl-2-oxo[1-14C]butyrate as a substrate. Intact fibroblasts from four classical MSUD patients showed no decarboxylation over a substrate concentration range of 0.25 to 5.0 mM, and thiamin (4 mM) was without effect. 3. The overall reaction of the multienzyme complex was efficiently reconstituted by using a disrupted-cell system. Normals again showed typical hyperbolic kinetics at the 2-oxo acid concentrations of 0.1 to 5 mM. The Vmax. and apparent Km values were 0.10 +/- 0.02 m-unit/mg of protein and 0.05-0.1 mM respectively, with 3-methyl-2-oxobutyrate. In contrast, classical MSUD patients exhibited sigmoidal kinetics (Hill coefficient, 2.5) with activity approaching 40-60% of the normal value at 5 mM substrate. The K0.5 values from the Hill plots for MSUD patients were 4-7 mM. 4. The E1 (branched-chain 2-oxo acid decarboxylase) component of the multienzyme complex was measured in disrupted-particulate preparations. Normals again showed hyperbolic kinetics with the 2-oxo acid, whereas MSUD preparations exhibited sigmoidal kinetics with the activity of E1 strictly dependent on substrate concentration. Apparent Km or K0.5 were 0.1 and 1.0 mM for normal and MSUD subjects respectively. 5. Measurements of E2 (dihydrolipoyl transacylase) and E3 (dihydrolipoyl dehydrogenase) in MSUD preparations showed them to be in the normal range. 6. The above data suggest a defect in the E1 step of branched-chain 2-oxo acid dehydrogenase in classical MSUD patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6895847      PMCID: PMC1163502          DOI: 10.1042/bj2000059

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Subcellular distribution and cofactor function of human branched chain alpha-ketoacid dehydrogenase in normal and mutant cultured skin fibroblasts.

Authors:  D J Danner; L J Elsas
Journal:  Biochem Med       Date:  1975-05

2.  Complementation analysis of maple syrup urine disease in heterokaryons derived from cultured human fibroblasts.

Authors:  L B Lyons; R P Cox; J Dancis
Journal:  Nature       Date:  1973-06-29       Impact factor: 49.962

3.  Rapid diagnosis of maple syrup urine disease (branched chain ketoaciduria) by micro-enzyme assay in leukocytes and fibroblasts.

Authors:  U Wendel; W Wöhler; H W Goedde; U Langenbeck; E Passarge; H W Rüdiger
Journal:  Clin Chim Acta       Date:  1973-05-30       Impact factor: 3.786

4.  Enzyme activity in classical and variant forms of maple syrup urine disease.

Authors:  J Dancis; J Hutzler; S E Snyderman; R P Cox
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

5.  Mammalian alpha-keto acid dehydrogenase complexes. VI. Nature of the multiple forms of pig heart lipoamide dehydrogenase.

Authors:  Y Sakurai; Y Fekuyoshi; M Hamada; T Hayakawa; M Koike
Journal:  J Biol Chem       Date:  1970-09-10       Impact factor: 5.157

6.  The enzyme defect in maple syrup urine disease (branched chain ketoaciduria).

Authors:  J E Seegmiller; R G Westall
Journal:  J Ment Defic Res       Date:  1967-12

7.  Modulation of branched-chain alpha-keto acid decarboxylase activity in rat liver mitochondria by hypophysectomy.

Authors:  S G Sullivan; J Dancis; R P Cox
Journal:  Arch Biochem Biophys       Date:  1976-09       Impact factor: 4.013

8.  A kinetic study of dihydrolipoyl transacetylase from bovine kidney.

Authors:  P J Butterworth; C S Tsai; M H Eley; T E Roche; L J Reed
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

9.  Intermittent branched-chain ketonuria. Variant of maple-syrup-urine disease.

Authors:  J Dancis; J Hutzler; T Rokkones
Journal:  N Engl J Med       Date:  1967-01-12       Impact factor: 91.245

10.  Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.

Authors:  U Wendel; H Wentrup; H W Rüdiger
Journal:  Pediatr Res       Date:  1975-09       Impact factor: 3.756

View more
  10 in total

1.  A structural abnormality of E1 component of the branched-chain alpha-keto acid dehydrogenase complex in maple syrup urine disease.

Authors:  Y Indo; A Kitano; I Akaboshi; F Endo; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

2.  Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate.

Authors:  D T Chuang; L S Ku; R P Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

3.  Altered kinetic properties of the branched-chain alpha-keto acid dehydrogenase complex due to mutation of the beta-subunit of the branched-chain alpha-keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease.

Authors:  Y Indo; A Kitano; F Endo; I Akaboshi; I Matsuda
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

4.  Detection of heterozygotes in maple-syrup-urine disease: measurements of branched-chain alpha-ketoacid dehydrogenase and its components in cell cultures.

Authors:  D T Chuang; L S Ku; D S Kerr; R P Cox
Journal:  Am J Hum Genet       Date:  1982-05       Impact factor: 11.025

5.  Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations.

Authors:  C W Fisher; C R Fisher; J L Chuang; K S Lau; D T Chuang; R P Cox
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

6.  Effects of diet and of alloxan-diabetes on the activity of branched-chain 2-oxo acid dehydrogenase complex and of activator protein in rat tissues.

Authors:  P A Patston; J Espinal; P J Randle
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

7.  Maple syrup urine disease: a possible biochemical basis for the clinical heterogeneity.

Authors:  Y Indo; I Akaboshi; Y Nobukuni; F Endo; I Matsuda
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

8.  Altered phosphorylation state of branched-chain 2-oxo acid dehydrogenase in a branched-chain acyltransferase deficient human fibroblast cell line.

Authors:  R S Eisenstein; G Hoganson; R H Miller; A E Harper
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

9.  Heterogeneous expression of protein and mRNA in pyruvate dehydrogenase deficiency.

Authors:  I D Wexler; D S Kerr; L Ho; M M Lusk; R A Pepin; A A Javed; J E Mole; B W Jesse; T J Thekkumkara; G Pons
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Maple syrup urine disease: two different forms within a single family.

Authors:  J Frézal; O Amédée-Manesme; G Mitchell; S Heuertz; F Rey; J Rey; J M Saudubray
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.